Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early-Stage Breast Carcinoma”

998 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 998 results

Not applicableLooking for participantsNCT03390894
What this trial is testing

Long-Term Follow-up Study of Early Stage Breast Cancer Patients Included in GEICAM Studies

Who this might be right for
Invasive Breast Cancer Early Stages
Spanish Breast Cancer Research Group 8,000
Not applicableNot Yet RecruitingNCT07244588
What this trial is testing

Shaving as an Safe Alternative to Frozen Section Analysis

Who this might be right for
Early Stage Breast Cancer
Mark Ezzat Gerges 30
Testing effectiveness (Phase 2)Looking for participantsNCT06444269
What this trial is testing

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 53
Not applicableEnrolling By InvitationNCT06834204
What this trial is testing

Advancing Care Coordination Between Cancer and Primary Care Teams for Complex Cancer Survivors

Who this might be right for
CancerBreast Cancer Early Stage Breast Cancer (Stage 1-3)Bladder Cancer+5 more
Rutgers, The State University of New Jersey 266
Large-scale testing (Phase 3)Active Not RecruitingNCT02568839
What this trial is testing

Neoadjuvant Response-guided Treatment of HER2 Positive Breast Cancer

Who this might be right for
Early-Stage Breast CarcinomaHER-2 Positive Breast Cancer
Thomas Hatschek 202
Post-approval studies (Phase 4)Study completedNCT05365230
What this trial is testing

Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast Cancer

Who this might be right for
Breast Cancer
Ottawa Hospital Research Institute 261
Testing effectiveness (Phase 2)UnknownNCT05556200
What this trial is testing

A Phase II Trial of Camrelizumab in Combination With Apatinib for Neoadjuvant Treatment of Early-stage TNBC With a High Proportion of TILs

Who this might be right for
Breast CancerTriple-Negative Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 58
Testing effectiveness (Phase 2)Looking for participantsNCT06150898
What this trial is testing

Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)

Who this might be right for
Early-stage Breast CancerEstrogen-receptor-positive Breast Cancer
Jules Bordet Institute 112
Not applicableActive Not RecruitingNCT07447544
What this trial is testing

Predictive Factors for CNS Metastases in Early Breast Cancer Using Liquid Biopsy (AKRA CŽS)

Who this might be right for
Breast CancerCentral Nervous System Metastases
Institute of Oncology Ljubljana 22
Testing effectiveness (Phase 2)Study completedNCT00394251
What this trial is testing

Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizumab as Adjuvant Therapy for Patients With Breast Cancer

Who this might be right for
Breast Cancer
Celgene 197
Not applicableLooking for participantsNCT04902937
What this trial is testing

Association of Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With Immunomodulation and Circulating Tumor Cell Phenotype in Relation to Patient Age.

Who this might be right for
Tumor Cell, Circulating
University of Jena 200
Not applicableUnknownNCT06311357
What this trial is testing

Percent Weight Change in the Medical Supplement Group of Early Breast Cancer

Who this might be right for
Early Stage Breast Cancer
Department of Medical Services Ministry of Public Health of Thailand 40
Not applicableStudy completedNCT00005957
What this trial is testing

Radiation Therapy in Treating Women Who Have Undergone Surgery for Early-Stage Invasive Breast Cancer

Who this might be right for
Breast Cancer
NCIC Clinical Trials Group 1,832
Testing effectiveness (Phase 2)UnknownNCT04247633
What this trial is testing

High Risk ER+HER2- T1-2N0-1 Early Breast Cancer With Palbociclib Plus Endocrine Therapy(HIPEx)

Who this might be right for
Breast Cancer
Samsung Medical Center 578
Not applicableStudy completedNCT03761420
What this trial is testing

Adjuvant Endocrine Therapy in Early Stage Breast Cancer: Adherence and Clinical Outcome

Who this might be right for
Breast Neoplasm
St. Olavs Hospital 1,411
Testing effectiveness (Phase 2)Looking for participantsNCT06927180
What this trial is testing

SHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)
Henan Cancer Hospital 180
Early research (Phase 1)Active Not RecruitingNCT04796220
What this trial is testing

Focused Ultrasound and Gemcitabine in Breast Cancer

Who this might be right for
Breast CancerBreast Neoplasms
Patrick Dillon, MD 32
Not applicableLooking for participantsNCT07021846
What this trial is testing

Dose Escalated Concomitant Boost Radiotherapy for Early Breast Cancer

Who this might be right for
Breast Cancer
Fondazione Policlinico Universitario Campus Bio-Medico 132
Not applicableActive Not RecruitingNCT01928589
What this trial is testing

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Who this might be right for
Breast CancerAdenocarcinoma of the Breast
Richard Zellars 81
Early research (Phase 1)Active Not RecruitingNCT05870579
What this trial is testing

[177Lu]Lu-NeoB in Combination With Ribociclib and Fulvestrant in Participants With ER+, HER2- and GRPR+ Advanced Breast Cancer

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 28
Next Page